{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:54:37Z","timestamp":1762905277796,"version":"3.45.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002384"],"award-info":[{"award-number":["UL1TR002384"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajogmf.2021.100463","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T19:21:08Z","timestamp":1628968868000},"page":"100463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between low fetal fraction and hypertensive disorders of pregnancy in in vitro fertilization\u2013conceived pregnancies"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8260-434X","authenticated-orcid":false,"given":"Kristen","family":"Cagino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Bortoletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"McCarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis P.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malavika","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.ajogmf.2021.100463_bib0001","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2018.03.048","article-title":"Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy","volume":"224","author":"Suzumori","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0006","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/humrep\/dey033","article-title":"Cell-free fetal DNA testing in singleton IVF conceptions","volume":"33","author":"Lee","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0007","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/humrep\/deaa110","article-title":"Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies","volume":"35","author":"Talbot","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0008","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/01.AOG.0000183593.24583.7c","article-title":"Assisted reproductive technology and pregnancy outcome","volume":"106","author":"Shevell","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0009","article-title":"Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies","volume":"105","author":"Qin","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.03.010","article-title":"Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles","volume":"221","author":"Ginstr\u00f6m Ernstad","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2019.03.033","article-title":"Maternal and neonatal outcomes associated with trophectoderm biopsy","volume":"112","author":"Zhang","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0012","first-page":"229","article-title":"Reproductive outcomes of women aged 40 and older undergoing IVF with donor sperm","volume":"36","author":"Bortoletto","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0013","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.fertnstert.2020.11.011","article-title":"Time from oocyte retrieval to frozen embryo transfer in the natural cycle does not impact reproductive or neonatal outcomes","volume":"115","author":"Bortoletto","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0014","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijgo.2016.04.007","article-title":"Comparison of perinatal outcomes following fresh and frozen-thawed blastocyst transfer","volume":"135","author":"Pereira","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0015","first-page":"1","article-title":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2431-3-6","article-title":"A nearly continuous measure of birth weight for gestational age using a United States national reference","volume":"3","author":"Oken","year":"2003","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/hr.2016.126","article-title":"Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis","volume":"40","author":"Umesawa","year":"2017","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0018","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing","volume":"36","author":"Krishna","year":"2016","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/16.2.221","article-title":"The impact of ovarian stimulation on implantation and fetal development in mice","volume":"16","author":"Ertzeid","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0022","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10815-015-0434-1","article-title":"Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles","volume":"32","author":"Pereira","year":"2015","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl","key":"10.1016\/j.ajogmf.2021.100463_bib0023","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.placenta.2010.06.018","article-title":"Cell-free nucleic acids as potential markers for preeclampsia","volume":"32","author":"Hahn","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0024","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.fertnstert.2013.09.025","article-title":"Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan","volume":"101","author":"Ishihara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humupd\/dmx031","article-title":"Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?","volume":"24","author":"Maheshwari","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajogmf.2021.100463_bib0026","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:50:18Z","timestamp":1762905018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933321001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2589933321001580"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100463","relation":{},"ISSN":["2589-9333"],"issn-type":[{"type":"print","value":"2589-9333"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between low fetal fraction and hypertensive disorders of pregnancy in in vitro fertilization\u2013conceived pregnancies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100463"}}